GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PeptiDream Inc (OTCPK:PPTDF) » Definitions » Debt-to-Equity

PPTDF (PeptiDream) Debt-to-Equity : 0.35 (As of Dec. 2024)


View and export this data going back to 2014. Start your Free Trial

What is PeptiDream Debt-to-Equity?

PeptiDream's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was $16.9 Mil. PeptiDream's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was $110.8 Mil. PeptiDream's Total Stockholders Equity for the quarter that ended in Dec. 2024 was $369.0 Mil. PeptiDream's debt to equity for the quarter that ended in Dec. 2024 was 0.35.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for PeptiDream's Debt-to-Equity or its related term are showing as below:

PPTDF' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.35   Med: 0.55   Max: 0.66
Current: 0.35

During the past 13 years, the highest Debt-to-Equity Ratio of PeptiDream was 0.66. The lowest was 0.35. And the median was 0.55.

PPTDF's Debt-to-Equity is ranked worse than
68.14% of 1017 companies
in the Biotechnology industry
Industry Median: 0.14 vs PPTDF: 0.35

PeptiDream Debt-to-Equity Historical Data

The historical data trend for PeptiDream's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PeptiDream Debt-to-Equity Chart

PeptiDream Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 0.66 0.55 0.35

PeptiDream Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.55 0.54 0.36 0.35 0.35

Competitive Comparison of PeptiDream's Debt-to-Equity

For the Biotechnology subindustry, PeptiDream's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PeptiDream's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PeptiDream's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where PeptiDream's Debt-to-Equity falls into.


;
;

PeptiDream Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

PeptiDream's Debt to Equity Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(16.858 + 110.793) / 369.031
=0.35

PeptiDream's Debt to Equity Ratio for the quarter that ended in Dec. 2024 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(16.858 + 110.793) / 369.031
=0.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PeptiDream  (OTCPK:PPTDF) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

PeptiDream Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of PeptiDream's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

PeptiDream Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PeptiDream Inc (OTCPK:PPTDF) » Definitions » Debt-to-Equity
Comparable Companies
TSE:4592 TSE:2160 TSE:4974 TSE:4565 TSE:4894 TSE:219A TSE:4593 TSE:4599 TSE:7776 TSE:4563 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
4587:Japan
Address
1-2-10, Nihonbashi, Chuo-ku, Toyo Building, 6th Floor, Tokyo, JPN, 103-0027
Website
http://www.peptidream.com
PeptiDream Inc is a biopharmaceutical company, engaged in the research and development of new pharmaceutical candidates. It discovers constrained peptides, small molecules, and peptide-drug conjugate therapeutics using its Peptide Discovery Platform System. The company aspires to be a leader in drug discovery and development to address unmet medical needs and improve the quality of life of patients worldwide.